KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Depreciation & Amortization (CF) (2016 - 2025)

Cardinal Health's Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $234.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 21.88% year-over-year to $234.0 million; the TTM value through Dec 2025 reached $883.0 million, up 19.81%, while the annual FY2025 figure was $790.0 million, 11.27% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $234.0 million at Cardinal Health, roughly flat from $233.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $234.0 million in Q4 2025 and bottomed at $164.0 million in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $179.5 million (2021), against an average of $186.5 million.
  • The largest annual shift saw Depreciation & Amortization (CF) fell 20.0% in 2021 before it rose 28.02% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $164.0 million in 2021, then rose by 3.66% to $170.0 million in 2022, then grew by 2.94% to $175.0 million in 2023, then rose by 9.71% to $192.0 million in 2024, then increased by 21.88% to $234.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Depreciation & Amortization (CF) are $234.0 million (Q4 2025), $233.0 million (Q3 2025), and $209.0 million (Q2 2025).